;

Antitrust, Competition, and Economic Regulation

Merger control, FDI, and FSR: Filing considerations for life sciences transactions

Blockbusters and market power: Patent playbooks under scrutiny

Legal scrutiny rising for algorithmic pricing in health care

Below-threshold scrutiny in EU life sciences deals

Zero-price and complimentary commercial models in Italy: regulatory and competition considerations

EU antitrust compliance in market access for combination therapies

Antitrust dawn raids in the EU: Dynamics, dos, and don'ts for life sciences companies

EU antitrust compliance in purely contractual global strategic pharmaceutical alliances